ALTACE
ALTACE
Approved
DIN Number
02221853
Drug Class
Human
Market Date
Mar 24, 1997
Company
HC
bausch health, canada inc.
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02221853
AIG Number0122858002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C09AA05 RAMIPRIL
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification24:32.04
Health Canada Classification
ACTIVE INGREDIENTS (1)
RAMIPRILActive
Strength: 10 MG
Monograph: RAMIPRIL